MENU

BBOT BridgeBio Oncology Therapeutics Inc Forecast, Technical & Fundamental Analysis

BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes... Show more

BBOT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
BBOT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

BBOT is expected to report earnings to rise 8.34% to -56 cents per share on November 18

BridgeBio Oncology Therapeutics Inc BBOT Stock Earnings Reports
Q3'26
Est.
$-0.57
Q1'26
Missed
by $0.06
Q4'25
Missed
by $0.07
The last earnings report on May 12 showed earnings per share of -52 cents, missing the estimate of -46 cents. With 1.05M shares outstanding, the current market capitalization sits at 394.46M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
256 East Grand Avenue
Phone
+1 650 405-4770
Employees
92
Web
https://www.bridgebio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APDYX23.820.11
+0.46%
Artisan Developing World Advisor
TSPFX5.33N/A
N/A
Transamerica Small Cap Growth R4
PALRX19.33N/A
N/A
PGIM Balanced R
SPMPX8.13N/A
N/A
Invesco SteelPath MLP Alpha Plus R5
PCUZX76.01N/A
N/A
T. Rowe Price U.S. Equity Research Z

BBOT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BBOT has been loosely correlated with NKTX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BBOT jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBOT
1D Price
Change %
BBOT100%
-10.33%
NKTX - BBOT
34%
Loosely correlated
+3.56%
VKTX - BBOT
32%
Poorly correlated
-0.47%
EPRX - BBOT
32%
Poorly correlated
+4.99%
MIST - BBOT
30%
Poorly correlated
-6.66%
ELVN - BBOT
30%
Poorly correlated
-3.40%
More
BridgeBio Oncology Therapeutics (BBOT) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com